13F Portfolios

Avidity Partners Management LP — PALVELLA THERAPEUTICS INC NE PVLA: Quarterly 13F Position History

Avidity Partners Management LP has reported PALVELLA THERAPEUTICS INC NE (PVLA) on 2 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2025. As of Q1 2026, the position is sized at 70,000 shares ($9.0M market value, 2.03% of the equity book). Quarter-over-quarter share count change: + 50,700 (+262.7%) .

Recent initiation: Avidity Partners Management LP first reported PVLA on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 70,000 +50,700 +262.7% $9.0M 2.03% $128.32
Q4 2025 19,300 $2.0M 0.58% $104.67

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Avidity Partners Management LP first disclose a PVLA position in 13F-HR filings?

Avidity Partners Management LP first reported PALVELLA THERAPEUTICS INC NE (PVLA) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Avidity Partners Management LP's most recent quarter-over-quarter share-count change in PVLA?

Between Q4 2025 and Q1 2026, Avidity Partners Management LP added 50,700 shares of PVLA (+262.7%), bringing the total reported position to 70,000 shares at a market value of $9.0M.

Does the implied price-per-share represent Avidity Partners Management LP's cost basis in PVLA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.